Role of Pharmacists and Pharmacy Teams in COVID-19 Response Bibliography

• John LL, Armbrust S, Haller IV, Renier CM, Brown A, Monson E. Evaluation of a pharmacist-led COVID-19 vaccination program in a hospital setting. J Pharm Pract. 2024 Aug;37(4):895-899. doi: 10.1177/08971900231189355. Epub 2023 Aug 19.
• Ryan GW, Kahl AR, Callaghan D, Kintigh B, Askelson NM. Locations of COVID-19 vaccination provision: urban-rural differences. J Rural Health. 2024 Jun;40(3):476-482. doi: 10.1111/jrh.12811. Epub 2023 Nov 13.
• Gates DM, Cohen SA, Orr K, Caffrey AR. Demographic and clinical predictors of pharmacist-administered pediatric influenza immunization. J Pharm Pract. 2024 Jun;37(3):612-624. doi:10.1177/08971900231155223
• Peel E, Orji CC, Ogan S, et al. Pharmacists' perceptions of mental well-being and immunization safety during COVID-19. J Pharm Pract. 2024 Jun;37(3):563-570. doi: 10.1177/08971900221149145. Epub 2022 Dec 27.
• Karavolis Z, Thacker E, Fabian T, et al. Pharmacist-implemented intervention to surmount COVID-19 vaccination hesitancy in adults with substance use disorders. Am J Health Syst Pharm. 2024 Apr 1:zxae095. doi: 10.1093/ajhp/zxae095. Online ahead of print.
• Bluml BM, Hamstra SA, Tonrey LL, Little JB, Bonham AJ, Grabenstein JD. Pharmacist assessments and care to improve adult vaccination rates: A report from project IMPACT vaccine confidence. J Am Pharm Assoc (2003). Mar 2024;64(3):102061. doi:10.1016/j.japh.2024.102061
• Shtaynberg J, Gim S, Cope R, et al. Pharmacy intern involvement in COVID-19 immunization practices in New York State. J Pharm Pract. 2024 Mar;37(3):656-664. doi:10.1177/08971900231164748
• Dudley MZ, Schuh HB, Forr A, Shaw J, Salmon DA. Changes in vaccine attitudes and recommendations among US Healthcare Personnel during the COVID-19 pandemic. NPJ Vaccines. 2024 Feb 28;9(1):49. doi: 10.1038/s41541-024-00826-y
• Carroll JC, Herbert SMC, Nguyen TQ, Schork CJ, Kampas LN, Rebitch CB. Vaccination equity and the role of community pharmacy in the United States: a qualitative study. Vaccine. 2024 Jan;42(3):564-572. doi:10.1016/j.vaccine.2023.12.063
• Fuschetto KS, Amin KA, Gothard MD, Merico EM. Evaluating the role of pharmacy technician-administered vaccines. J Pharm Pract. 2023 Dec;36(6):1383-1391. doi:10.1177/08971900221117893
• Curran G, Mosley C, Gamble A, et al. Addressing COVID-19 vaccine hesitancy in rural community pharmacies: a protocol for a stepped wedge randomized clinical trial. Implement Sci. 2023 Dec;18(1):72. Published 2023 Dec 18. doi:10.1186/s13012-023-01327-7
• Kahaleh AA, Ellington TM, Coker AO, et al. Impact of COVID-19 on pharmacy education and practice: strategies to boost advocacy and unity among health care organizations. Am J Pharm Educ. 2023 Dec;87(12):100091. doi: 10.1016/j.ajpe.2023.100091. Epub 2023 Nov 11.
• Leslie KF, Waltz P, DeJarnett B, Fuller LZ, Lisenby S, Raake SE. Evaluation of technician immunization administration. J Am Pharm Assoc (2003). 2023 Nov-Dec;63(6):1715-1721. doi: 10.1016/j.japh.2023.07.008. Epub 2023 Aug 2.
• Ryan GW, Kahl AR, Callaghan D, Kintigh B, Askelson NM. Locations of COVID-19 vaccination provision: urban-rural differences. J Rural Health. Published online November 13, 2023. doi:10.1111/jrh.12811
• Whitner C, Curtis SD, Allen JM, Duane KJ. Community champions: the crucial contribution of an independent pharmacy in COVID-19 vaccination efforts in an underserved community. Int J Environ Res Public Health. 2023 Oct 3;20(19):6881. doi: 10.3390/ijerph20196881
• Beam TA, Klepser DG, Klepser ME, et al. COVID-19 host genetic risk study conducted at community pharmacies: implications for public health, research and pharmacists' scope of practice. Res Social Adm Pharm. 2023 Oct;19(10):1360-1364. doi: 10.1016/j.sapharm.2023.06.003. Epub 2023 Jun 14.
• Jackson J, Guirguis E, Sourial M, Pirmal S, Pinder L. Preparing student-pharmacists to utilize motivational interviewing techniques to address COVID-19 vaccine hesitancy in underrepresented racial/ethnic patient populations. Curr Pharm Teach Learn. 2023 Aug;15(8):742-747. doi: 10.1016/j.cptl.2023.07.008. Epub 2023 Jul 21.
• Nawas GT, Zeidan RS, Edwards CA, El-Desoky RH. Barriers to COVID-19 vaccines and strategies to improve acceptability and uptake. J Pharm Pract. 2023 Aug;36(4):900-904. doi: 10.1177/08971900221081621. Epub 2022 Apr 23.
• Skoy E, Rubinstein EB, Nagel L, Preugschas AH, Larson M. Preparedness for a pandemic: independent community pharmacists' experiences delivering COVID-19 vaccines. J Am Pharm Assoc (2003). 2023 Jul-Aug;63(4):1049-1056. doi: 10.1016/j.japh.2023.03.008. Epub 2023 Mar 30.
• Herrman A, Ruisinger JF, Moore EE, Melton BL. Assessing the impact of a pharmacy-provided personalized vaccination recommendation on immunization rates of adolescents. J Am Pharm Assoc (2003). 2023 Jul-Aug;63(4S):S43-S47. doi:10.1016/j.japh.2022.10.017
• Singleton BA, Al-Dahir S, Gillard C, et al. Perceived role, identity and experiences of pharmacists and the potential impact on COVID-19 vaccine uptake per Louisiana region: a prospective cohort study. Int J Environ Res Public Health. 2023 Jul 27;20(15):6459. doi: 10.3390/ijerph20156459
• Titus-Lay E, Nehira J, Courtney J, et al. A pharmacist-led community-based survey study: determining the impact of the Covid-19 pandemic on actionable factors associated with worse cancer outcomes and cancer health disparities. Explor Res Clin Soc Pharm. 2023;11:100311. Published 2023 Jul 13. doi:10.1016/j.rcsop.2023.100311
• Stewart-Lynch A, Lombardo S, Ceriani D, Mastrangelo S. Well Child Wednesdays: an interprofessional pilot-program to increase pediatric immunizations post-COVID. J Interprof Educ Pract. 2023 Jun;31:100606. doi:10.1016/j.xjep.2023.100606  
• Chen JC, Gutierrez G, Kamran R, et al. Evaluation of COVID-19 vaccine implementation in a large safety net health system. Front Health Serv. 2023;3:1152523. Published 2023 Jun 5. doi:10.3389/frhs.2023.1152523
• McCormick N, Jackson BN, Durham SH, Hohmann NS, Westrick SC. Qualitative analysis of community pharmacy-based COVID-19 immunization service operations. J Am Pharm Assoc (2003). 2023 Jun;63(5):1574-1582.e6. doi:10.1016/j.japh.2023.06.022
• Bacci JL, Shah PD, Arnold J, Atkins DL, Weiner BJ. Readying community pharmacies to participate in COVID-19 testing and vaccination. Disaster Med Public Health Prep. 2023 Jun 29;17:e424. doi: 10.1017/dmp.2023.84. PMID: 37381676.
• Raut A, Samad A, Verma J, Kshirsagar P. Acceptance, hesitancy and refusal towards COVID-19 vaccination. Clin Epidemiol Glob Health. 2023 May-Jun;21:101283. doi: 10.1016/j.cegh.2023.101283. Epub 2023 Apr 4.
• Vernon V, Patel J, Cieri-Hutcherson NE, et al. The impact of COVID-19 on select considerations in patients of reproductive age: brief talking points for pharmacists. J Am Pharm Assoc (2003). 2023 May-Jun;63(3):720-724. doi: 10.1016/j.japh.2023.01.003. Epub 2023 Jan 11.
• Liu I, Cruz A, Gamcsik S, Harris SC. Reducing barriers to COVID-19 vaccine uptake through a culturally sensitive pharmacy-led patient medication education group in a behavioral health population. J Am Pharm Assoc (2003). May-Jun 2023;63(3):915-919. doi:10.1016/j.japh.2023.01.012
• Luo J, Hur K, Salone C, et al. Incidence rates and clinical characteristics of patients with confirmed myocarditis or pericarditis following COVID-19 mRNA vaccination: experience of the Veterans Health Administration through 9 October 2022. Open Forum Infect Dis. 2023 May 17;10(7):ofad268. doi: 10.1093/ofid/ofad268
• LaFleur GE, Azzi AG, Schimmel SM, Howard MS. Technology targeting immunocompromised patients for COVID-19 vaccine in community pharmacies. Res Social Adm Pharm. 2023 Apr;19(4):610-614. doi:10.1016/j.sapharm.2022.11.013
• Varisco TJ, Downs CG, Sansgiry SS, Al Saadi R, Hastings T, Thornton JD. Parents' intention to have their child vaccinated at a community pharmacy: a national cross-sectional survey. J Am Pharm Assoc (2003). 2023 Mar-Apr;63(2):511-517.e8. doi:10.1016/j.japh.2022.10.008
• Goode JR, Cook P, Cuttino S, Pollard S. Evaluation of a team-based quality improvement initiative for influenza vaccination in an underserved population. J Am Pharm Assoc (2003). 2023 Mar-Apr;63(2):667-671. doi:10.1016/j.japh.2022.11.014
• Watson KE, Lee DH, Nusair MB, Al Hamarneh YN. Impact of the Novel CoronaviruS (COVID-19) on Frontline PharmacIsts Roles and ServicEs: INSPIRE Worldwide Survey. Pharmacy (Basel). 2023 Mar 29;11(2):66. doi: 10.3390/pharmacy11020066
• Aqel O, Alqadheeb B, Felix M, et al. Cultivating COVID-19 vaccine confidence in pharmacy professionals. Pharmacy (Basel). 2023 Mar 7;11(2):50. doi: 10.3390/pharmacy11020050
• Mercadante AR, Chen AMH, Chu V, Wong JC, Law AV. Examining general vaccine acceptance and COVID-19 vaccine intention: comparison across pharmacies in California and Ohio. Pharmacy (Basel). 2023 Feb 27;11(2):46. doi: 10.3390/pharmacy11020046
• Lewin BJ, Bronstein D, Tubert JE, et al. COVID-19 vaccine concerns of health care providers and ancillary staff. Pediatr Res. 2023 Feb;93(3):460-462. doi: 10.1038/s41390-022-02171-z. Epub 2022 Jun 18.
• Woodard L, Gilbert L, King B, et al. Examining Black and Hispanic physicians and other healthcare providers' attitudes toward the COVID-19 vaccine. J Natl Med Assoc. 2023 Feb;115(1):53-65. doi: 10.1016/j.jnma.2022.12.001. Epub 2023 Jan 5.
• Koskan AM, LoCoco IE, Daniel CL, Teeter BS. Rural Americans' COVID-19 vaccine perceptions and willingness to vaccinate against COVID-19 with their community pharmacists: an exploratory study. Vaccines (Basel). 2023 Jan 13;11(1):171. doi: 10.3390/vaccines11010171
• Gamble A, Hastings TJ, Westrick SC, et al. COVID-19 booster vaccination in rural community pharmacies. Vaccine. 2023 Jan 27;41(5):999-1002. doi: 10.1016/j.vaccine.2022.12.050. Epub 2022 Dec 26.
• Kuehn M, LaMori J, DeMartino JK, et al. Assessing barriers to access and equity for COVID-19 vaccination in the US. BMC Public Health. 2022 Dec 3;22(1):2263. doi: 10.1186/s12889-022-14636-1
• McKeirnan KC, Motzner MS, Kherghehpoush S. Examining routine pediatric vaccination availability in community pharmacies in Washington State. Pharmacy (Basel). 2022 Dec;10(6):156. Published 2022 Nov 22. doi:10.3390/pharmacy10060156
• Wilson G, Aremu TO. The Federal Retail Pharmacy Program (FRPP) impact on COVID-19 vaccine distribution during pandemic: effectiveness, limitations, and implications. Innov Pharm. 2022 Dec 12;13(3):10.24926/iip.v13i3.5026. doi: 10.24926/iip.v13i3.5026
• Brown C, Morlock A, Blakolmer K, Heidari E, Morlock R. COVID-19 vaccination and race - a nationwide survey of vaccination status, intentions, and trust in the US general population. J Manag Care Spec Pharm. 2022 Dec;28(12):1429-1438. doi: 10.18553/jmcp.2022.28.12.1429
• Grabenstein JD. Essential services: Quantifying the contributions of America's pharmacists in COVID-19 clinical interventions. J Am Pharm Assoc (2003). 2022 Nov-Dec;62(6):1929-1945.e1. doi: 10.1016/j.japh.2022.08.010. Epub 2022 Aug 18.
• Gillard CJ, Al-Dahir S, Earls M, Singleton B. A culturally competent vaccine hesitancy educational model for community pharmacists to increase vaccine uptake, Louisiana, 2021-2022. Am J Public Health. Nov 2022;112(S9):S900-S903. doi:10.2105/AJPH.2022.307070
• Gessler CA, Richardson RM, Hall DL, Coley KC. Operationalizing pandemic vaccinations at a regional supermarket chain pharmacy. Disaster Med Public Health Prep. 2022 Oct;16(5):2070-2075. doi:10.1017/dmp.2021.43
• Nguyen E, Wright M, Oliphant C, et al. Patient-guided talking points to address COVID-19 and general vaccine hesitancy. Pharmacy (Basel). 2022 Oct 20;10(5):137. doi: 10.3390/pharmacy10050137
• Hurley-Kim K, Babish K, Chen E, et al. The U.S. travel health pharmacists' role in a post-COVID-19 pandemic era. Pharmacy (Basel). 2022 Oct 15;10(5):134. doi: 10.3390/pharmacy10050134
• Wittenauer R, Shah PD, Bacci JL, Stergachis A. Pharmacy deserts and COVID-19 risk at the census tract level in the State of Washington. Vaccine X. 2022 Oct 17;12:100227. doi: 10.1016/j.jvacx.2022.100227
• Ashcraft AM, Ponte CD, Farjo S, Dotson S, Murray PJ. The [underutilized] power of independent pharmacies to promote public health in rural communities: a call to action. J Am Pharm Assoc (2003). Sep 2022;62(1):38-41. doi:10.1016/j.japh.2021.09.002
• Owusu KA, Effendi MK, Thompson Bastin ML, Tirmizi S, Lat I, Ammar MA. Narrative review: addressing Covid-19 vaccine concerns in special and vulnerable populations. Hosp Pharm. 2022 Aug;57(4):575-587. doi: 10.1177/00185787211066463. Epub 2022 Jan 19.
• Osibanjo O, Benkstein K, Slater J, Shah A. The role of managed care clinical pharmacists in improving COVID-19 vaccination rates for culturally specific Medicaid populations. J Am Coll Clin Pharm. 2022 Aug;5(8):812-820. doi: 10.1002/jac5.1662
• Abdul-Mutakabbir JC, Simiyu B, Walker RE, Christian RL, Dayo Y, Maxam M. Leveraging Black pharmacists to promote equity in COVID-19 vaccine uptake within Black communities: a framework for researchers and clinicians. J Am Coll Clin Pharm. 2022 Aug;5(8):887-893. doi: 10.1002/jac5.1669. Epub 2022 Jun 27.
• DiMario A, McCall KL, Couture S, Boynton W. Pharmacist and pharmacy technician attitudes and experiences with technician-administered immunizations. Vaccines (Basel). 2022 Aug;10(8):1354. Published 2022 Aug 19. doi:10.3390/vaccines10081354
• Garofoli GK, Gálvez-Peralta M, Barrickman AL, et al. Establishment and evaluation of scalable COVID-19 vaccine clinics at a large university. J Am Pharm Assoc (2003). 2022 Jul-Aug;62(4):1430-1437. doi: 10.1016/j.japh.2022.03.022. Epub 2022 Mar 31.
• Carpenter DM, Hastings T, Westrick S, et al. Rural community pharmacists' ability and interest in administering COVID-19 vaccines in the southern United States. J Am Pharm Assoc (2003). 2022 Jul-Aug;62(4):1379-1383. doi: 10.1016/j.japh.2022.01.013. Epub 2022 Jan 19.
• Hughes DM, Mordino J. Pharmacist responsiveness and readiness for oral antivirals for COVID-19: a rebuttal to the AMA statement regarding the Biden administration's test-to-treat plan. J Am Pharm Assoc (2003). 2022 Jul-Aug;62(4):1162-1164. doi: 10.1016/j.japh.2022.03.023. Epub 2022 Apr 1.
• Mercer J, Liang A, Yoon J, Nguyen J, Carroll JC, Coley KC. COVID-19 pandemic vaccination preparedness strategies for independent community pharmacies. J Am Pharm Assoc (2003). 2022 Jul-Aug;62(4):1172-1178.e3. doi: 10.1016/j.japh.2022.01.003. Epub 2022 Jan 6.
• Amundson CJ, Sias JJ, Frietze GA. Perceptions of COVID-19 vaccines in a predominantly Hispanic patient population from the Texas-Mexico border. J Am Pharm Assoc (2003). 2022 Jul-Aug;62(4S):S17-S21.e2. doi:10.1016/j.japh.2021.11.003
• Luli AJ, Morello CM, Lorentz SM, Bounthavong M, Brandl K, Hart LA. A systematic approach to providing COVID-19 vaccinations in the community by student pharmacists. Pharmacy (Basel). 2022 Jul 30;10(4):93. doi: 10.3390/pharmacy10040093
• Durand C, Douriez E, Chappuis A, et al. Contributions and challenges of community pharmacists during the COVID-19 pandemic: a qualitative study. J Pharm Policy Pract. 2022 Jun 16;15(1):43. doi: 10.1186/s40545-022-00438-8
• Wyte-Lake T, Manheim C, Gillespie SM, Dobalian A, Haverhals LM. COVID-19 vaccination in VA home based primary care: experience of interdisciplinary team members. J Am Med Dir Assoc. 2022 Jun;23(6):917-922. doi: 10.1016/j.jamda.2022.03.014. Epub 2022 Apr 4.
• Davis TC, Beyl R, Bhuiyan MAN, et al. COVID-19 concerns, vaccine acceptance and trusted sources of information among patients cared for in a safety-net health system. Vaccines (Basel). 2022 Jun 10;10(6):928. doi: 10.3390/vaccines10060928
• Hess K, Bach A, Won K, Seed SM. Community pharmacists roles during the COVID-19 pandemic. J Pharm Pract. 2022 Jun;35(3):469-476. doi: 10.1177/0897190020980626. Epub 2020 Dec 15.
• Rusgis MM, Bays JE, Abt RM, Sperry ML. Impact of COVID-19 health information sources on student vaccine hesitancy. Curr Pharm Teach Learn. 2022 Apr;14(4):468-475. doi: 10.1016/j.cptl.2022.02.004. Epub 2022 Mar 7.
• Kulczycki A, Shewchuk R. Back to basics: a general approach to improving Covid and adult immunization delivery focused on pharmacy-based immunization services. Vaccine. 2022 Apr;40(19):2647-2649. doi:10.1016/j.vaccine.2022.03.038
• Axon DR, Cernasev A, Desai M, Connor SE, Jonkman LJ, Sekar MC. Evaluating students' COVID-19 Knowledge, Attitudes and Practices (COVKAP) during the COVID-19 pandemic. Pharmacy (Basel). 2022 Apr 18;10(2):46. doi: 10.3390/pharmacy10020046
• Cohrs JR, Mirtallo JM, Seifert JL, Jones SM, Erdmann AM, Li J. Perceptions and barriers to the annual influenza vaccine compared with the coronavirus disease 2019 vaccine in an urban underserved population. J Am Pharm Assoc (2003). 2022 Mar-Apr;62(2):461-467.e1. doi:10.1016/j.japh.2021.10.019
• Grabenstein JD. Vaccine humanity. J Am Pharm Assoc (2003). 2022 Jan-Feb;62(1):286-287. doi: 10.1016/j.japh.2021.11.018. Epub 2021 Nov 19.
• Meyer BA, Viskupič F, Wiltse DL. Pharmacists to partner with religious leaders to overcome vaccine hesitancy among Christians. J Am Pharm Assoc (2003). 2022 Jan-Feb;62(1):302-304. doi:10.1016/j.japh.2021.08.025
• Akpoji U, Amos ME, McMillan K, Sims S, Rife K. Exercising empathy: pharmacists possess skills to increase coronavirus vaccine confidence. J Am Pharm Assoc (2003). 2022 Jan-Feb;62(1):296-301. doi:10.1016/j.japh.2021.07.016
• Purnell M, Maxwell T, Hill S, et al. Exploring COVID-19 vaccine hesitancy at a rural historically black college and university. J Am Pharm Assoc (2003). 2022 Jan-Feb;62(1):340-344. doi: 10.1016/j.japh.2021.09.008. Epub 2021 Oct 1.
• Doyno CR, Fitzgerald JM, White CM, Sobieraj DM, Zacchera M. Innovative partnership in Connecticut to expand health professional eligibility to administer COVID-19 vaccines. J Am Pharm Assoc (2003). 2022 Jan-Feb;62(1):247-252. doi:10.1016/j.japh.2021.08.013
• Taddio A, Morrison J, Gudzak V, et al. Integration of CARD (Comfort Ask Relax Distract) for COVID-19 community pharmacy vaccination in children: effect on implementation outcomes. Can Pharm J (Ott). 2022 Jan-Feb;156(1 Suppl):36S-47S. Published 2022 Dec 13. doi:10.1177/17151635221139783
• Shen AK, Tan ASL. Trust, influence, and community: why pharmacists and pharmacies are central for addressing vaccine hesitancy. J Am Pharm Assoc (2003). 2022 Jan-Feb;62(1):305-308. doi: 10.1016/j.japh.2021.10.001. Epub 2021 Oct 8.
• Brauer E, Choi K, Chang J, et al. Health care providers' trusted sources for information about COVID-19 vaccines: mixed methods study. JMIR Infodemiology. 2021 Dec;1(1):e33330. Published 2021 Dec 8. doi:10.2196/33330
• Stoa MK, Frail CK, Farley JF, Pestka DL, Blanchard CM. Adaptations made to delivery of comprehensive medication management in the community pharmacy setting during COVID-19. Explor Res Clin Soc Pharm. 2021 Dec;4:100089. doi:10.1016/j.rcsop.2021.100089
• Riley AC, Campbell H, Butler L, Wisseh C, Nonyel NP, Shaw TE. Socialized and traumatized: pharmacists, underserved patients, and the COVID-19 vaccine. J Am Pharm Assoc (2003). 2021 Nov-Dec;61(6):e2-e5. doi: 10.1016/j.japh.2021.05.020. Epub 2021 Jun 1.
• Yarnoff B, Bodhaine S, Cohen E, Buck PO. Time and cost of administering COVID-19 mRNA vaccines in the United States. Hum Vaccin Immunother. 2021 Nov 2;17(11):3871-3875. doi: 10.1080/21645515.2021.1974289. Epub 2021 Oct 6.
• Patel N, Bouchard J, Oliver MB, Badowski ME, Carreno JJ; Society of Infectious Diseases Pharmacists. Early clinical trial data and real-world assessment of COVID-19 vaccines: insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2021 Oct;41(10):837-850. doi: 10.1002/phar.2622
• Gravlee E, Pittman E, Sparkmon W, Imeri H, Cox HF, Barnard M. COVID-19 vaccination engagement and barriers among Mississippi pharmacists. Pharmacy (Basel). 2021 Oct 13;9(4):167. doi: 10.3390/pharmacy9040167
• Chan A, Joe MD, Hirsch JD. Supporting COVID-19 vaccine rollout before charter class arrives: the University of California, Irvine experience. Pharmacy (Basel). 2021;9(4):164. Published 2021 Oct 9. doi:10.3390/pharmacy9040164
• Bakken BK, Winn AN. Clinician burnout during the COVID-19 pandemic before vaccine administration. J Am Pharm Assoc (2003). 2021 Sep-Oct;61(5):e71-e77. doi:10.1016/j.japh.2021.04.009
• Shallal A, Abada E, Musallam R, et al. Evaluation of COVID-19 vaccine attitudes among Arab American healthcare professionals living in the United States. Vaccines (Basel). 2021 Sep;9(9):942. Published 2021 Aug 24. doi:10.3390/vaccines9090942
• Mercadante AR, Law AV. Will they, or won't they? Examining patients' vaccine intention for flu and COVID-19 using the Health Belief Model. Res Social Adm Pharm. 2021 Sep;17(9):1596-1605. doi: 10.1016/j.sapharm.2020.12.012. Epub 2020 Dec 30.
• Marwitz KK, Haugtvedt C, Kostrzewa AB. Support pharmacy infrastructure to strengthen US COVID-19 vaccination efforts and beyond. Am J Public Health. 2021 Jul;111(7):1204-1206. doi: 10.2105/AJPH.2021.306314
• Traynor K. Pharmacists promote COVID-19 vaccine acceptance in rural locales. Am J Health Syst Pharm. 2021 Jul 22;78(15):1361-1362. doi: 10.1093/ajhp/zxab250
• Jacob SS, Bridgeman MB, Kim H, et al. Pharmacists' perceptions and drivers of immunization practices for COVID-19 vaccines: results of a nationwide survey prior to COVID-19 vaccine emergency use authorization. Pharmacy (Basel). 2021 Jul 26;9(3):131. doi: 10.3390/pharmacy9030131
• Robke JT, Niss H, Woods TM. Optimizing student pharmacists' contributions to patient care during a pandemic. Am J Health Syst Pharm. 2021 Jun;78(18):1665-1667. doi:10.1093/ajhp/zxab235
• Grindrod K, Waite N, Constantinescu C, Watson KE, Tsuyuki RT. COVID-19 vaccine hesitancy: pharmacists must be proactive and move the middle. Can Pharm J. 2021 Apr 19;154(3):133-135. doi: 10.1177/17151635211005763
• Marwitz KK. The pharmacist's active role in combating COVID-19 medication misinformation. J Am Pharm Assoc (2003). 2021 Mar-Apr;61(2):e71-e74. doi:10.1016/j.japh.2020.10.022
• Vordenberg SE, Diez HL, Ferguson C, Walker PC, Bostwick JR, Klein KC. Practical considerations for community-based health promotion events during the COVID-19 pandemic. Innov Pharm. 2021;12(2):10.24926/iip.v12i2.3487. Published 2021 Mar 30. doi:10.24926/iip.v12i2.3487
• Moore AF, Tilson EC, Wong CA. Sidebar: North Carolina's process for developing our COVID-19 vaccine plan. N C Med J. 2021 Mar;82(2):127-128. doi:10.18043/ncm.82.2.127
• Andrade J, Slaby M, DeAngelis J, et al. Implementation of a pharmacist-led COVID-19 vaccination clinic at a community teaching hospital. Am J Health Syst Pharm. 2021 Mar;78(12):1038-1042. doi:10.1093/ajhp/zxab135
• MacArthur RB, Bentur OS, MacArthur IC, et al. CTSA pharmacies: contribution to research and public health during the COVID-19 pandemic. J Clin Transl Sci. 2021 Feb 18;5(1):e108. doi: 10.1017/cts.2021.13
• Paul AK, Bogart T, Schaber AR, Cutchins DC, Robinson RF. Alaska pharmacists: first responders to the pandemic in the last frontier. J Am Pharm Assoc (2003). 2021 Jan-Feb;61(1):e35-e38. doi:10.1016/j.japh.2020.09.008
• Aruru M, Truong HA, Clark S. Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond. Res Social Adm Pharm. 2021 Jan;17(1):1967-1977. doi: 10.1016/j.sapharm.2020.04.002. Epub 2020 Apr 10.
• ASHP principles for COVID-19 vaccine distribution, allocation, and mass immunization. Am J Health Syst Pharm. 2020 Dec 4;77(24):2112-2113. doi: 10.1093/ajhp/zxaa311
• Strand MA, Bratberg J, Eukel H, Hardy M, Williams C. Community pharmacists' contributions to disease management during the COVID-19 pandemic. Prev Chronic Dis. 2020 Jul 23;17:E69. doi: 10.5888/pcd17.200317. Erratum in: Prev Chronic Dis. 2020 Sep 03;17:E98. doi: 10.5888/pcd17.200317e
• McElhiney LF. Pharmacies on the frontline: responding to the COVID-19 pandemic. Int J Pharm Compd. 2020 Jul-Aug;24(4):287-295.
• Elbeddini A, Prabaharan T, Almasalkhi S, Tran C. Pharmacists and COVID-19. J Pharm Policy Pract. 2020 Jun 19;13:36. doi: 10.1186/s40545-020-00241-3